Phibro Animal Health Corporation (NASDAQ:PAHC) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On May 8, 2017, Phibro Animal Health Corporation issued a press
release announcing its operating results for the third quarter of
the fiscal year ending June 30, 2017. A copy of the press release
is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this report, including the exhibit
attached hereto, is being furnished and shall not be deemed to be
filed for purposes of Section 18 of, or otherwise regarded as
filed under, the Securities Exchange Act of 1934, as amended (the
Exchange Act), nor shall it be deemed incorporated by reference
into any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.
ITEM 8.01 OTHER EVENTS
On May 8, 2017, Phibro Animal Health Corporation issued a press
release announcing the declaration of a quarterly cash dividend
of $0.10 per share on its Class A common stock and Class B common
stock, payable on June 22, 2017, to stockholders of record at the
close of business on May 31, 2017. A copy of the press release
announcing the dividend is filed as Exhibit 99.2 to this Current
Report on Form 8-K and is incorporated herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
|
Exhibit Number |
Description | |
| 99.1 | Press Release, dated May 8, 2017. | |
| 99.2 | Press Release, dated May 8, 2017. |
About Phibro Animal Health Corporation (NASDAQ:PAHC)
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company’s Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company’s MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium. Phibro Animal Health Corporation (NASDAQ:PAHC) Recent Trading Information
Phibro Animal Health Corporation (NASDAQ:PAHC) closed its last trading session down -0.35 at 29.85 with 78,936 shares trading hands.
